Alebund Pharmaceuticals Announces First Participant Randomized and Dosed in Global Phase IIb Multi-Regional Clinical Trial of AP306 for Hyperphosphatemia
SHANGHAI, July 21, 2026 /PRNewswire/ — Alebund Pharmaceuticals (Jiangsu) Limited…
July 21, 2026
The Art of Happiness: Nationwide Children's Art Competition Celebrates Young Creativity in Vietnam
HO CHI MINH CITY, Vietnam, July 21, 2026 /PRNewswire/ — Young artists across…
July 21, 2026
Tuya Smart Accelerates Physical AI Commercialization with Strategic Investment in Robopoet